《美股》道指早段好淡爭持 英特爾揚4% 蘋果吐1%
市場等待本週通脹數據,美股週一早段靠穩。道指高開8點,報44,184點,早段好淡爭持,最新跌約20點。標普500指數近平開報6,389點;納指高開9點,報21,459點。
據報英偉達(NVDA.US)及AMD(AMD.US)同意向美國政府支付中國AI晶片銷售15%收入,兩股早段變化不大。
蘋果(AAPL.US)有所回吐,最新跌逾1%。特斯拉(TSLA.US)揚逾3%。Meta(META.US)偏軟。
英特爾(INTC.US)股價早段升逾4%,據報CEO陳立武將與美國總統特朗普會面。美光科技(MU.US)上調季度盈收預測,股價漲約4%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.